Current Radiotherapy Considerations for Nasopharyngeal Carcinoma.
adaptive planning
artificial intelligence
nasopharyngeal cancer
particle therapy
radiotherapy
target delineation
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
24 Nov 2022
24 Nov 2022
Historique:
received:
26
10
2022
revised:
21
11
2022
accepted:
21
11
2022
entrez:
11
12
2022
pubmed:
12
12
2022
medline:
12
12
2022
Statut:
epublish
Résumé
Radiotherapy is the primary treatment modality for nasopharyngeal carcinoma (NPC). Successful curative treatment requires optimal radiotherapy planning and precise beam delivery that maximizes locoregional control while minimizing treatment-related side effects. In this article, we highlight considerations in target delineation, radiation dose, and the adoption of technological advances with the aim of optimizing the benefits of radiotherapy in NPC patients.
Identifiants
pubmed: 36497254
pii: cancers14235773
doi: 10.3390/cancers14235773
pmc: PMC9736118
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
JAMA Netw Open. 2021 Jun 1;4(6):e2113205
pubmed: 34143193
Int J Part Ther. 2021 Jun 25;8(1):119-130
pubmed: 34285941
Radiother Oncol. 2022 Jul;172:10-17
pubmed: 35500787
Br J Radiol. 2015 Sep;88(1053):20150052
pubmed: 26111068
Lancet Oncol. 2022 Apr;23(4):479-490
pubmed: 35240053
Radiology. 2019 Jun;291(3):677-686
pubmed: 30912722
Int J Radiat Oncol Biol Phys. 2010 Mar 1;76(3 Suppl):S50-7
pubmed: 20171518
Int J Radiat Oncol Biol Phys. 2006 Nov 15;66(4):981-91
pubmed: 17145528
Int J Radiat Oncol Biol Phys. 2021 Dec 1;111(5):1227-1236
pubmed: 34418466
J Med Imaging Radiat Oncol. 2018 May 28;:
pubmed: 29808625
Radiother Oncol. 2014 Jan;110(1):172-81
pubmed: 24183870
Int J Radiat Oncol Biol Phys. 2011 May 1;80(1):148-53
pubmed: 20605352
Acta Oncol. 2020 May;59(5):541-548
pubmed: 32090645
J Cancer Res Clin Oncol. 2022 Aug;148(8):1931-1942
pubmed: 35486182
Front Oncol. 2021 Jul 23;11:653050
pubmed: 34367954
Cancer. 2012 Oct 1;118(19):4892-900
pubmed: 22359313
Int J Radiat Oncol Biol Phys. 2022 May 1;113(1):101-113
pubmed: 35074433
Oral Oncol. 2018 Nov;86:8-18
pubmed: 30409324
Med Dosim. 2021 Spring;46(1):39-44
pubmed: 32768273
Radiat Oncol. 2013 Jan 24;8:20
pubmed: 23347410
N Engl J Med. 2019 Sep 19;381(12):1124-1135
pubmed: 31150573
Radiother Oncol. 2011 Jan;98(1):23-7
pubmed: 21040992
PLoS One. 2015 Apr 27;10(4):e0124018
pubmed: 25915944
Med Phys. 2019 Sep 16;:
pubmed: 31529501
Radiother Oncol. 2020 Dec;153:55-66
pubmed: 32920005
J Cancer. 2019 Aug 28;10(21):5057-5064
pubmed: 31602257
Int J Radiat Oncol Biol Phys. 2019 Jul 15;104(4):836-844
pubmed: 30954521
Oral Oncol. 2022 Nov;134:106139
pubmed: 36179488
Int J Radiat Oncol Biol Phys. 2019 Mar 1;103(3):654-668
pubmed: 30712708
Oral Oncol. 2018 Feb;77:16-21
pubmed: 29362121
Radiother Oncol. 2018 Jan;126(1):25-36
pubmed: 29153464
Clin Oncol (R Coll Radiol). 2012 Apr;24(3):196-207
pubmed: 21752615
Acta Oncol. 2019 Apr;58(4):472-474
pubmed: 30669927
Head Neck. 2016 Apr;38 Suppl 1:E468-72
pubmed: 25677692
Int J Radiat Oncol Biol Phys. 2022 May 1;113(1):114-116
pubmed: 35427543
Int J Radiat Oncol Biol Phys. 2019 Nov 1;105(3):567-580
pubmed: 31276776
Head Neck. 2009 Jan;31(1):52-7
pubmed: 18972423
Cancer Manag Res. 2022 Jan 26;14:339-366
pubmed: 35115832
BMC Cancer. 2017 Oct 11;17(1):678
pubmed: 29020937
Radiother Oncol. 2022 May;170:136-142
pubmed: 35288229
Int J Radiat Oncol Biol Phys. 2018 Mar 15;100(4):891-902
pubmed: 29485068
Head Neck. 2016 Apr;38 Suppl 1:E1886-95
pubmed: 26705956
J Cancer. 2017 Oct 17;8(18):3718-3724
pubmed: 29151959
Radiother Oncol. 2012 Dec;105(3):273-82
pubmed: 23245644
Radiother Oncol. 2012 Sep;104(3):286-93
pubmed: 22995588
Cancers (Basel). 2021 Jul 16;13(14):
pubmed: 34298769
Radiother Oncol. 2022 Nov 11;178:109414
pubmed: 36375563
Int J Radiat Oncol Biol Phys. 2013 Jan 1;85(1):e47-54
pubmed: 23122981
BMC Cancer. 2018 Dec 10;18(1):1234
pubmed: 30526538
Radiother Oncol. 2019 Aug;137:9-15
pubmed: 31048235
Clin Transl Oncol. 2017 Apr;19(4):470-476
pubmed: 27718153
Oral Oncol. 2020 Nov;110:104862
pubmed: 32615440
Eur Arch Otorhinolaryngol. 2021 Mar;278(3):763-769
pubmed: 32623508
Oral Oncol. 2012 Sep;48(9):864-9
pubmed: 22445296
Radiat Oncol. 2021 Apr 1;16(1):64
pubmed: 33794949
BMC Cancer. 2012 Mar 21;12:98
pubmed: 22433671
Transl Oncol. 2022 Feb;16:101324
pubmed: 34953342
Int J Radiat Oncol Biol Phys. 2006 Feb 1;64(2):374-81
pubmed: 16213105
Head Neck. 2021 Jun;43(6):1949-1963
pubmed: 33780074
Radiother Oncol. 2018 Jan;126(1):3-24
pubmed: 29180076
Radiother Oncol. 2012 Sep;104(3):324-30
pubmed: 22236614
Radiother Oncol. 2020 Jul;148:140-142
pubmed: 32361663
Radiother Oncol. 2018 Sep;128(3):472-478
pubmed: 29731161
Strahlenther Onkol. 2012 Mar;188(3):282-6
pubmed: 22314578
Int J Radiat Oncol Biol Phys. 2021 Mar 1;109(3):801-812
pubmed: 33068690
Front Oncol. 2020 Aug 20;10:1572
pubmed: 32974193
Radiother Oncol. 2021 Mar;156:251-257
pubmed: 33418007
Radiat Oncol. 2014 Feb 19;9:60
pubmed: 24552293
J Clin Oncol. 2007 Nov 1;25(31):4873-9
pubmed: 17971582
Radiother Oncol. 2020 Jan;142:115-123
pubmed: 31653573
Radiother Oncol. 2022 Nov 11;177:205-213
pubmed: 36375564
Front Oncol. 2017 Dec 20;7:315
pubmed: 29376025
Radiat Oncol. 2022 Mar 12;17(1):52
pubmed: 35279160
Radiat Oncol. 2017 Jan 13;12(1):15
pubmed: 28587681
Radiother Oncol. 2018 Jan;126(1):37-42
pubmed: 28864073
Radiother Oncol. 2019 Sep;138:93-98
pubmed: 31252300
Magn Reson Imaging. 2021 Nov;83:50-56
pubmed: 34246785
Eur Radiol. 2019 Apr;29(4):1961-1967
pubmed: 30302589
Klin Padiatr. 2016 Apr;228(3):105-12
pubmed: 27135270
Clin Transl Radiat Oncol. 2022 Aug 23;37:41-56
pubmed: 36065359
Radiother Oncol. 2014 Mar;110(3):390-7
pubmed: 24721546
J Clin Oncol. 2022 Apr 10;40(11):1163-1173
pubmed: 34990291
Cancer Sci. 2019 Sep;110(9):2867-2874
pubmed: 31237050
Med Dosim. 2019 Autumn;44(3):226-232
pubmed: 30268345
Cancers (Basel). 2019 Mar 17;11(3):
pubmed: 30884910
Lancet Oncol. 2016 Nov;17(11):1509-1520
pubmed: 27686945